杨咏强,危少华,田野.肝细胞癌合并门静脉癌栓的联合放疗的综合治疗进展[J].中华放射医学与防护杂志,2021,41(5):396-399
肝细胞癌合并门静脉癌栓的联合放疗的综合治疗进展
Recent advances in the combined use of radiation therapy and multimodality therapies for hepatocellular carcinoma with portal vein tumor thrombus
投稿时间:2020-08-29  
DOI:10.3760/cma.j.issn.0254-5098.2021.05.014
中文关键词:  肝肿瘤,原发性  放射治疗  门静脉癌栓
英文关键词:Liver neoplasms, primary  Radiotherapy  Portal vein tumor thrombus
基金项目:
作者单位E-mail
杨咏强 苏州大学附属第二医院放疗科 215004  
危少华 苏州大学附属第二医院肝胆外科 215004 shaohuawei2010@sina.com 
田野 苏州大学附属第二医院放疗科 215004  
摘要点击次数: 1792
全文下载次数: 954
中文摘要:
      肝细胞癌发生及发展过程中易侵犯门静脉形成门静脉癌栓,由于预后极差且缺乏有效的治疗手段,是影响肝癌整体疗效提高的瓶颈。肝癌合并门静脉癌栓的最佳治疗方法仍存在争议。随着技术的发展,放疗对于门静脉癌栓治疗的安全性和有效性已得到广泛证实。个体化及综合治疗的进一步优化是未来的研究方向。本文探讨肝细胞癌合并门静脉癌栓放疗及综合治疗的现状和未来前景。
英文摘要:
      Hepatocellular carcinoma (HCC) is prone to invading portal vein system known as portal vein tumor thrombus (PVTT). PVTT is one of the main reasons for poor prognosis of HCC because of its rapid progress and lack of effective treatments, and the optimal treatment strategy remains controversial. With recent advances in techniques, the efficacy and safety of radiation therapy for PVTT has been improved. The optimization of individualized radiotherapy and multimodality treatment is the future direction of research. In this review, we will investigate the current state and future opportunities of radiation therapy and multimodality treatment for HCC with PVTT.
HTML  查看全文  查看/发表评论  下载PDF阅读器
关闭